{"title": "Products | GSK US", "author": null, "url": "https://us.gsk.com/en-us/products/", "hostname": "gsk.com", "description": "Learn more about our product portfolio and how we're prioritizing vaccines and specialty medicines to get ahead of disease together", "sitename": "Gsk", "date": "2023-01-01", "cleaned_text": "Filter by product strain)||Vaccines| |FluLaval (trivalent) & FluLaval (quadrivalent)||seasonal influenza vaccine strain)||Vaccines| |Havrix||hepatitis cannot provide comprehensive information about our products here, in compliance with regulations. If you are a healthcare professional, you can access more product information on our [GSKPro website.](https://gskpro.com/) In the US, if you are a patient and have questions about our medicines, please contact the [GSK Response Center](https://contactus.gsk.com/). Our product areas Vaccines Vaccines Our unrivalled vaccine portfolio targets infectious diseases at every stage of life. From adjuvants that improve vaccine effectiveness, through to mRNA technology, we use advanced technologies and collaborate with our partners to develop new, more effective vaccines that help people around the world to get ahead of disease. Specialty medicines Specialty medicines As our experts seek innovative new ways to treat the human body, specialty medicines are at the forefront of our high-value pipeline of new products. We are global leaders in developing medicines for respiratory disease and HIV, and we are building our presence in other therapeutic areas such as immunology and oncology. General medicines General medicines General medicines are usually prescribed in primary care or community settings by general healthcare practitioners. For us, this includes our medicines for inhaled respiratory, dermatology and other diseases. These vital medications are the engine room for GSK, supporting hundreds of millions of people to enjoy a better everyday quality of life. "}